Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Restless legs syndrome induced by topiramate: two more cases.

Literature DB >> 19444538

Restless legs syndrome induced by topiramate: two more cases.

Pedro Emilio Bermejo.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2009 PMID： 19444538 DOI： 10.1007/s00415-009-0073-5

Source DB: PubMed Journal: J Neurol ISSN： 0340-5354 Impact factor: 4.849

× No keyword cloud information.

14 in total

1. Dopaminergic neurotransmission and restless legs syndrome: a genetic association analysis.

Authors: A Desautels; G Turecki; J Montplaisir; N Ftouhi-Paquin; M Michaud; V A Chouinard; G A Rouleau
Journal: Neurology Date: 2001-10-09 Impact factor: 9.910

2. Pilot trial of lamotrigine in the restless legs syndrome.

Authors: Eriene A Youssef; Mary L Wagner; Jaime O Martinez; Wayne Hening
Journal: Sleep Med Date: 2004-12-25 Impact factor: 3.492

3. Restless legs syndrome induced by zonisamide.

Authors: Pedro Emilio Bermejo Velasco; Juan Antonio Zabala Goiburu; Rafael Saez Pinel
Journal: Mov Disord Date: 2007-07-30 Impact factor: 10.338

4. Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of Parkinson's disease.

Authors: Monty A Silverdale; S L Nicholson; A R Crossman; J M Brotchie
Journal: Mov Disord Date: 2005-04 Impact factor: 10.338

5. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders.

Authors: Catharine A Winstanley; David E H Theobald; Jeffrey W Dalley; Trevor W Robbins
Journal: Neuropsychopharmacology Date: 2005-04 Impact factor: 7.853

6. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study.

Authors: D Garcia-Borreguero; O Larrosa; Y de la Llave; K Verger; X Masramon; G Hernandez
Journal: Neurology Date: 2002-11-26 Impact factor: 9.910

Review 7. Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate.

Authors: Mikael Angehagen; Elinor Ben-Menachem; Lars Rönnbäck; Elisabeth Hansson
Journal: Neurochem Res Date: 2003-02 Impact factor: 3.996

Review 8. Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence?

Authors: Bankole A Johnson
Journal: Addict Behav Date: 2004-09 Impact factor: 3.913

Restless legs syndrome induced by topiramate: two more cases.

1. Dopaminergic neurotransmission and restless legs syndrome: a genetic association analysis.

2. Pilot trial of lamotrigine in the restless legs syndrome.

3. Restless legs syndrome induced by zonisamide.

4. Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of Parkinson's disease.

5. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders.

6. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study.

Review 7. Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate.

Review 8. Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence?

9. Restless legs with antiepileptic drug therapy.

10. Carbamazepine in restless legs. A controlled pilot study.

Review 1. Restless legs syndrome: pathophysiology, clinical presentation and management.

Review 2. Antiseizure Drugs and Movement Disorders.

3. Topiramate-induced periodic limb movement disorder in a patient affected by focal epilepsy.